The current MA risk adjustment model has shortcomings, both in predictive accuracy and payment equity across the Medicare ...
Objective To evaluate the association between use of newer glucagon-like peptide-1 receptor agonists (GLP-1 RAs; semaglutide, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results